Global Gastrointestinal Disorder Therapeutics Market Research Report 2023

Report ID: 1898267 | Published Date: Oct 2024 | No. of Page: 94 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Irritable Bowel Syndrome (IBS)
        1.2.3 Chronic Constipation (CC)
        1.2.4 Ulcerative Colitis (UC)
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Disorder Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gastrointestinal Disorder Therapeutics Market Perspective (2017-2028)
    2.2 Gastrointestinal Disorder Therapeutics Growth Trends by Region
        2.2.1 Gastrointestinal Disorder Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gastrointestinal Disorder Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Gastrointestinal Disorder Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Gastrointestinal Disorder Therapeutics Market Dynamics
        2.3.1 Gastrointestinal Disorder Therapeutics Industry Trends
        2.3.2 Gastrointestinal Disorder Therapeutics Market Drivers
        2.3.3 Gastrointestinal Disorder Therapeutics Market Challenges
        2.3.4 Gastrointestinal Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gastrointestinal Disorder Therapeutics Players by Revenue
        3.1.1 Global Top Gastrointestinal Disorder Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gastrointestinal Disorder Therapeutics Revenue
    3.4 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio
        3.4.1 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Disorder Therapeutics Revenue in 2021
    3.5 Gastrointestinal Disorder Therapeutics Key Players Head office and Area Served
    3.6 Key Players Gastrointestinal Disorder Therapeutics Product Solution and Service
    3.7 Date of Enter into Gastrointestinal Disorder Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Disorder Therapeutics Breakdown Data by Type
    4.1 Global Gastrointestinal Disorder Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Type (2023-2028)
5 Gastrointestinal Disorder Therapeutics Breakdown Data by Application
    5.1 Global Gastrointestinal Disorder Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gastrointestinal Disorder Therapeutics Market Size (2017-2028)
    6.2 North America Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022)
    6.3 North America Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Gastrointestinal Disorder Therapeutics Market Size (2017-2028)
    7.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Gastrointestinal Disorder Therapeutics Market Size (2017-2028)
    9.2 Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Detail
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Introduction
        11.1.4 AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.1.5 AstraZeneca Recent Development
    11.2 Takeda Pharmaceutical
        11.2.1 Takeda Pharmaceutical Company Detail
        11.2.2 Takeda Pharmaceutical Business Overview
        11.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Introduction
        11.2.4 Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.2.5 Takeda Pharmaceutical Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Detail
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Introduction
        11.3.4 Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Development
    11.4 Eisai
        11.4.1 Eisai Company Detail
        11.4.2 Eisai Business Overview
        11.4.3 Eisai Gastrointestinal Disorder Therapeutics Introduction
        11.4.4 Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.4.5 Eisai Recent Development
    11.5 Abbott Laboratories
        11.5.1 Abbott Laboratories Company Detail
        11.5.2 Abbott Laboratories Business Overview
        11.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Introduction
        11.5.4 Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.5.5 Abbott Laboratories Recent Development
    11.6 Salix Pharmaceuticals
        11.6.1 Salix Pharmaceuticals Company Detail
        11.6.2 Salix Pharmaceuticals Business Overview
        11.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Introduction
        11.6.4 Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.6.5 Salix Pharmaceuticals Recent Development
    11.7 Bausch Health
        11.7.1 Bausch Health Company Detail
        11.7.2 Bausch Health Business Overview
        11.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Introduction
        11.7.4 Bausch Health Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.7.5 Bausch Health Recent Development
    11.8 Allergan
        11.8.1 Allergan Company Detail
        11.8.2 Allergan Business Overview
        11.8.3 Allergan Gastrointestinal Disorder Therapeutics Introduction
        11.8.4 Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.8.5 Allergan Recent Development
    11.9 Bayer
        11.9.1 Bayer Company Detail
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Gastrointestinal Disorder Therapeutics Introduction
        11.9.4 Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.9.5 Bayer Recent Development
    11.10 UCB
        11.10.1 UCB Company Detail
        11.10.2 UCB Business Overview
        11.10.3 UCB Gastrointestinal Disorder Therapeutics Introduction
        11.10.4 UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.10.5 UCB Recent Development
    11.11 AbbVie
        11.11.1 AbbVie Company Detail
        11.11.2 AbbVie Business Overview
        11.11.3 AbbVie Gastrointestinal Disorder Therapeutics Introduction
        11.11.4 AbbVie Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.11.5 AbbVie Recent Development
    11.12 GlaxoSmithKline
        11.12.1 GlaxoSmithKline Company Detail
        11.12.2 GlaxoSmithKline Business Overview
        11.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Introduction
        11.12.4 GlaxoSmithKline Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.12.5 GlaxoSmithKline Recent Development
    11.13 Astellas Pharma
        11.13.1 Astellas Pharma Company Detail
        11.13.2 Astellas Pharma Business Overview
        11.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Introduction
        11.13.4 Astellas Pharma Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022)
        11.13.5 Astellas Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Irritable Bowel Syndrome (IBS)
    Table 3. Key Players of Chronic Constipation (CC)
    Table 4. Key Players of Ulcerative Colitis (UC)
    Table 5. Global Gastrointestinal Disorder Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Gastrointestinal Disorder Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gastrointestinal Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Gastrointestinal Disorder Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Gastrointestinal Disorder Therapeutics Market Share by Region (2023-2028)
    Table 11. Gastrointestinal Disorder Therapeutics Market Trends
    Table 12. Gastrointestinal Disorder Therapeutics Market Drivers
    Table 13. Gastrointestinal Disorder Therapeutics Market Challenges
    Table 14. Gastrointestinal Disorder Therapeutics Market Restraints
    Table 15. Global Gastrointestinal Disorder Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Gastrointestinal Disorder Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Gastrointestinal Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2021)
    Table 18. Ranking of Global Top Gastrointestinal Disorder Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Gastrointestinal Disorder Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Gastrointestinal Disorder Therapeutics Product Solution and Service
    Table 22. Date of Enter into Gastrointestinal Disorder Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. AstraZeneca Company Detail
    Table 43. AstraZeneca Business Overview
    Table 44. AstraZeneca Gastrointestinal Disorder Therapeutics Product
    Table 45. AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. AstraZeneca Recent Development
    Table 47. Takeda Pharmaceutical Company Detail
    Table 48. Takeda Pharmaceutical Business Overview
    Table 49. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product
    Table 50. Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Takeda Pharmaceutical Recent Development
    Table 52. Johnson & Johnson Company Detail
    Table 53. Johnson & Johnson Business Overview
    Table 54. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product
    Table 55. Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. Johnson & Johnson Recent Development
    Table 57. Eisai Company Detail
    Table 58. Eisai Business Overview
    Table 59. Eisai Gastrointestinal Disorder Therapeutics Product
    Table 60. Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Eisai Recent Development
    Table 62. Abbott Laboratories Company Detail
    Table 63. Abbott Laboratories Business Overview
    Table 64. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product
    Table 65. Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Abbott Laboratories Recent Development
    Table 67. Salix Pharmaceuticals Company Detail
    Table 68. Salix Pharmaceuticals Business Overview
    Table 69. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product
    Table 70. Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Salix Pharmaceuticals Recent Development
    Table 72. Bausch Health Company Detail
    Table 73. Bausch Health Business Overview
    Table 74. Bausch Health Gastrointestinal Disorder Therapeutics Product
    Table 75. Bausch Health Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Bausch Health Recent Development
    Table 77. Allergan Company Detail
    Table 78. Allergan Business Overview
    Table 79. Allergan Gastrointestinal Disorder Therapeutics Product
    Table 80. Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Allergan Recent Development
    Table 82. Bayer Company Detail
    Table 83. Bayer Business Overview
    Table 84. Bayer Gastrointestinal Disorder Therapeutics Product
    Table 85. Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Bayer Recent Development
    Table 87. UCB Company Detail
    Table 88. UCB Business Overview
    Table 89. UCB Gastrointestinal Disorder Therapeutics Product
    Table 90. UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. UCB Recent Development
    Table 92. AbbVie Company Detail
    Table 93. AbbVie Business Overview
    Table 94. AbbVie Gastrointestinal Disorder TherapeuticsProduct
    Table 95. AbbVie Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. AbbVie Recent Development
    Table 97. GlaxoSmithKline Company Detail
    Table 98. GlaxoSmithKline Business Overview
    Table 99. GlaxoSmithKline Gastrointestinal Disorder TherapeuticsProduct
    Table 100. GlaxoSmithKline Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. GlaxoSmithKline Recent Development
    Table 102. Astellas Pharma Company Detail
    Table 103. Astellas Pharma Business Overview
    Table 104. Astellas Pharma Gastrointestinal Disorder TherapeuticsProduct
    Table 105. Astellas Pharma Revenue in Gastrointestinal Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. Astellas Pharma Recent Development
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Disorder Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Irritable Bowel Syndrome (IBS) Features
    Figure 3. Chronic Constipation (CC) Features
    Figure 4. Ulcerative Colitis (UC) Features
    Figure 5. Global Gastrointestinal Disorder Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Gastrointestinal Disorder Therapeutics Report Years Considered
    Figure 10. Global Gastrointestinal Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Gastrointestinal Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Gastrointestinal Disorder Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Gastrointestinal Disorder Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Gastrointestinal Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Gastrointestinal Disorder Therapeutics Revenue in 2021
    Figure 16. North America Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Gastrointestinal Disorder Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gastrointestinal Disorder Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Gastrointestinal Disorder Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. AstraZeneca Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 45. Takeda Pharmaceutical Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 47. Eisai Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 48. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 49. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 50. Bausch Health Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 51. Allergan Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 52. Bayer Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 53. UCB Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 54. AbbVie Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 55. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 56. Astellas Pharma Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma
Frequently Asked Questions
Gastrointestinal Disorder Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Disorder Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Disorder Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gear Box Housing

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More